BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 2838420)

  • 21. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
    Rosenthal MD; Franson RC
    J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP
    J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187.
    Roubin R; Elsas PP; Fiers W; Dessein AJ
    Clin Exp Immunol; 1987 Nov; 70(2):484-90. PubMed ID: 2827923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
    Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
    Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes.
    Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F
    Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative degradation of leukotriene C4 by human monocytes and monocyte-derived macrophages.
    Neill MA; Henderson WR; Klebanoff SJ
    J Exp Med; 1985 Nov; 162(5):1634-44. PubMed ID: 3932580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate.
    McColl SR; Hurst NP; Betts WH; Cleland LG
    Biochem Biophys Res Commun; 1987 Sep; 147(2):622-6. PubMed ID: 2820409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and release of leukotriene C4 by human eosinophils.
    Owen WF; Soberman RJ; Yoshimoto T; Sheffer AL; Lewis RA; Austen KF
    J Immunol; 1987 Jan; 138(2):532-8. PubMed ID: 3025300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma.
    Arm JP; Horton CE; House F; Clark TJ; Spur BW; Lee TH
    Am Rev Respir Dis; 1988 Jul; 138(1):47-53. PubMed ID: 2849339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids.
    Haurand M; Flohé L
    Biochem Pharmacol; 1989 Jul; 38(13):2129-37. PubMed ID: 2735951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium ionophore, phorbol ester, and chemotactic peptide-induced cytoskeleton reorganization in human neutrophils.
    Howard TH; Wang D
    J Clin Invest; 1987 May; 79(5):1359-64. PubMed ID: 3106415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism.
    Hamasaki T; Sakano T; Kobayashi M; Sakura N; Ueda K; Usui T
    Eur J Clin Invest; 1989 Aug; 19(4):404-11. PubMed ID: 2550242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U937 and THP-1 cells do not release LTB4, LTC4, or LTD4 in response to A23187.
    Nolfo R; Rankin JA
    Prostaglandins; 1990 Feb; 39(2):157-65. PubMed ID: 2156322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemiluminescence properties of human, canine and rat polymorphonuclear cells.
    Lindena J; Burkhardt H
    J Biolumin Chemilumin; 1990; 5(3):165-70. PubMed ID: 2220415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Casein-derived peptides can modulate the production of 5-hydroxyeicosatetraenoic acid in human neutrophils.
    Rabgaoui N; Guérin MC; Torreilles J
    Biochem Cell Biol; 1994; 72(7-8):305-11. PubMed ID: 7893470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
    Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
    J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential generation of leukotriene C4 by human eosinophils.
    Shaw RJ; Cromwell O; Kay AB
    Clin Exp Immunol; 1984 Jun; 56(3):716-22. PubMed ID: 6086189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.